Despite Grindeks submitted arguments, evidence and justifications, the World Anti-Doping Agency (WADA) included meldonium in the Prohibited list. In accordance with the results of the...
Today, on 26 February, the JSC Grindeks submitted the non-audited consolidated financial statements of 2015 to Nasdaq Riga. Non-audited financial results indicate that the Group’s...
JSC Grindeks will publish its: non-audited financial statement for the 12-month period of 2015 on February 26, 2016; non-audited interim financial statement for the 3-month...
Today, on 27 November, the JSC Grindeks submitted the non-audited consolidated financial statements for the nine months of 2015 to “Nasdaq Riga”. Non-audited financial results...
From 13th to 15th of October, 2015, Grindeks and its subsidiary “Kalceks” participate in the leading pharmaceutical exhibition “CPhI Worldwide 2015” in Madrid, Spain. During...
JSC Grindeks announces that due to technical issues JSC Grindeks announcements published in the Nasdaq news distribution service system (GlobeNewswire) on 09 January, 2015, 27...
JSC Grindeks announces it has received a certificate approving the adequacy of its Energy management to the requirements of LVS EN ISO 50001:2012 standard. To...
JSC Grindeks announced today it has concluded a long-term cooperation agreement with the World Health Organization (WHO) on the oxytocin supplies. In accordance with the...
Today, on 4 September the joint stock company Grind will be visited by the Governor of Ulyanovsk Oblast (Russia) Sergey Morozov and his delegation. During...
Today, on 28 August, the JSC Grindekssubmitted the non-audited consolidated financial statements for the first six months of 2015 to Nasdaq Riga. Non-audited financial results...
Today, on 6 July, JSC Grindeks submitted to Nasdaq Riga the companys’ Annual Report and the Corporate Social Responsibility Report for the year 2014 (to...
1. Reports of Board, Supervisory Council, Audit Committee and statement of Sworn Auditor To take notice of the reports of the Board, the Supervisory Council,...
Today, on 29 May, the JSC Grindeks submitted the non-audited consolidated financial statements for the first quarter of 2015 to “Nasdaq Riga”. Non-audited financial results...
JSC Grindeks informs, it has introduced the final dosage form (capsule) of Ursodeoxycholic acid (UDCA) and started its export to Russia and Georgia. It is...
Today, on 30 April, the JSC Grindeks submitted the audited consolidated financial statements for twelve months of 2014 to “Nasdaq Riga”. Audited financial results indicate...
